Sunday, July 6, 2025
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
    Unlocking the Secrets of GLP-1 Medications

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
    Navigating the Medical Licensing Maze

    Navigating the Medical Licensing Maze

    April 4, 2025
    The Alarming Truth About Health Insurance Denials

    The Alarming Truth About Health Insurance Denials

    February 3, 2025
    Telehealth in Turmoil

    The Importance of NIH Grants

    January 31, 2025
  • Surveys

    Surveys

    What concerns you most about your healthcare?

    What concerns you most about your healthcare?

    July 1, 2025
    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    June 4, 2025

    Survey Results

    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
    Unlocking the Secrets of GLP-1 Medications

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
    Navigating the Medical Licensing Maze

    Navigating the Medical Licensing Maze

    April 4, 2025
    The Alarming Truth About Health Insurance Denials

    The Alarming Truth About Health Insurance Denials

    February 3, 2025
    Telehealth in Turmoil

    The Importance of NIH Grants

    January 31, 2025
  • Surveys

    Surveys

    What concerns you most about your healthcare?

    What concerns you most about your healthcare?

    July 1, 2025
    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    June 4, 2025

    Survey Results

    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Card Stacking COVID-19 Boosters

Daily Remedy by Daily Remedy
September 20, 2021
in Politics & Law
0

Last week the FDA approved a booster dose of the COVID-19 vaccine for patients above the age of 65 and for those who are at high risk of COVID-19 related complications.

The approval came in the final minutes of a contentious FDA hearing, after committee members voted against vaccine boosters for the general public. After struggling to identify a clinical basis that would justify booster doses in select high risk patient populations, the FDA committee took a ten minute break.

During that break they wrote a new question.

Instead of seeking approval for the general population, the new question, written by FDA committee members during the break, would seek approval for select high risk populations – those above the age of 65 and those who are at high risk of COVID-19 related complications.

It was apparent to everyone observing the proceedings the FDA committee wanted to approve the boosters – but only for selection populations. A live blog from STAT News reveals their obvious intentions.

“It became abundantly clear, during the discussion ahead of the voting question, that the panel was not going to vote to approve booster shots for a broad population. They were worried about the safety of the vaccine in younger people, and many said that the situation in Israel did not map to the one in the U.S. Eric Rubin, the Harvard professor and New England Journal of Medicine editor, commented that because of low vaccination rates, the benefit of boosters in controlling the pandemic might be limited.

So Peter Marks, the FDA official, and Arnold Monto, the panel’s chair, hatched a new plan. The panel would vote on the original question — the resounding 16-2 no vote — and then, after the vote, the panel made suggestions on a new question.

It’s clear they think a booster may be appropriate for older people — likely those over 60 or 65. They also wanted to make it available to those who are at higher risk from Covid, such as health care workers, people or are obese, and those who have diabetes. The FDA took took a 10 minute break to write a new question.”

The newly contrived question was oddly direct and decidedly biased in its phrasing:

“Based on the totality of scientific evidence available, including the safety and effectivenes data from clinical trial C4591001, do the known and potential benefits outweigh the known and potential risks of a Pfizer-BioNTech Covid-19 vaccine booster dose administered at least 6 months after the completion of the primary series for use in:

Individuals 65 years of age and older and

Individuals at high risk of severe covid-19”

To no one’s surprise, the committee then voted unanimously in favor of booster doses for this select population. The outcome was a foregone conclusion. They had already revealed their hand earlier in the hearing.

Although the outcome may appear clinically sensible, we are alarmed at the ad hoc manner in which the committee deliberated through its decision-making, overtly rephrasing topics and questions in a near whimsical manner.

There is a term for this – card stacking, a well known logical fallacy that appears when deliberate action is taken to bias an argument, with opposing evidence being recontexualized or discredited.

The FDA wanted to approve booster doses, but only for select patient populations. So they biased the question and quorum to produce the intended results. But biasing a deliberation to influence the likelihood of a desired outcome eliminates the purpose of the deliberation in the first place. Regardless of whether that outcome is the one supported by the scientific community in the United States.

In an age where distrust in centralized institutions is at an all-time high, the FDA and other organizations should take extra precautions to ensure the public that they are making decisions diligently.

But rewriting and factitiously voting on manufactured questions only reinforces the public’s distrust. Justifiably so, after all few can give credence to an organization that intersperses anecdotal evidence and conjecture alongside data from randomized controlled trials as though the quality of information is comparable.

One of the most viral sound bites from the hearing came from Dr. David Portnoy, Branch Chief at FDA Center for Tobacco Products, who bemused he would like booster doses for populations 60 and older, not 65 and older because of his own age – “I’m 63, so I like the 60 age instead of the 65 age.”

The available data is already limited in its quality. As many participating in the conference noted, we cannot directly apply Israeli data to the American population. We have a lower vaccination rate compared to Israel, which would reduce the benefits of a booster dose in the United States. And the data coming from Israel is still evolving and subject to change the longer the patients given booster doses are monitored.

This makes the need for proper deliberations all the more essential. This also makes what transpired all the more disappointing.

Most damaging of all, this latest hearing casts aspersions on earlier deliberations the FDA conducted over the course of the pandemic. After all, if the FDA conducted this latest hearing in an overtly biased manner, then we can only assume it has always made pandemic-based decisions this way.

Uncheck biases repeated over time create greater opportunities for a significant error. And if we do not correct course, then we may be priming ourselves for such an error.

Maybe not though, maybe we will somehow make it out of this pandemic. If we do, then it will not be because of the FDA, it will be despite the FDA.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. David Acevedo says:
    4 years ago

    The higher the ‘office’ the bigger the motive for bias.
    A condo in the Caymans or a new home high on a wooded valley or on a quiet river will mean little when these snakes, cowards, liars and thieves must face their God.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

In this episode of the Daily Remedy Podcast, Dr. Jeffrey Singer discusses his book 'Your Body, Your Health Care,' emphasizing the importance of patient autonomy in healthcare decisions. He explores historical cases that shaped medical ethics, the contradictions in harm reduction policies, and the role of the FDA in drug approval processes. Dr. Singer critiques government regulations that infringe on individual autonomy and advocates for a healthcare system that respects patients as autonomous adults. The conversation highlights the need for a shift in how healthcare policies are formulated, focusing on individual rights and self-medication.

Chapters

00:00 Introduction to Dr. Jeffrey Singer and His Book
01:11 The Importance of Patient Autonomy
10:29 Contradictions in Harm Reduction Policies
20:48 The Role of the FDA in Drug Approval
30:21 Certificate of Need Laws and Their Impact
39:59 The Legacy of Patient Autonomy and the Hippocratic Oath
Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer
YouTube Video _IWv1EYeJYQ
Subscribe

RFK Jr.’s Overhaul of CDC Vaccine Policy

Visuals

Official MAHA Report

Official MAHA Report

by Daily Remedy
May 31, 2025
0

Explore the official MAHA Report released by the White House in May 2025.

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • The First FBI Agent I Met

    3 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • Continuous Care, Continuous Data: How AI-Powered Remote Monitoring Redefines Diagnostics

    1 shares
    Share 0 Tweet 0
  • When Algorithms Chase Profits: Big Tech’s AI Race and the Price of Patient Care

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2025 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2025 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do